Artax Biopharma Inc.

The biopharmaceutical industry has been through a tremendous period of company creation, and even with a drop in financings during 2022 and 2023 from record levels of funding in 2020 and 2021, the las

Venture capital investors continue to show their enthusiasm for drug development, despite the relative pessimism of their peers investing in publicly traded biopharmaceutical companies, by putting the

IN VITRO DIAGNOSTICS Ativa Medical Corp. Ativa Medical closes $23mm Series B round to support micro lab development Diagnostics firm Ativa Medical Corp. raised $23mm through its Series B round

With new investment from former Genzyme Corp. CEO Henri Termeer and Advent Life Sciences, Artax Biopharma Inc. came out of stealth Sept. 21 eager to identify the most promising autoimmune indi